CART-meso-19 T cells / University of Pennsylvania, Novartis - LARVOL DELTA

Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer (clinicaltrials.gov) - P1; N=12; Active, not recruiting; Sponsor: University of Pennsylvania; Trial primary completion date: Sep 2016 ➔ Sep 2017

Trial primary completion date • Biosimilar • Gastrointestinal Cancer • Oncology • Pancreatic Cancer

Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer (clinicaltrials.gov) - P1; N=4; Terminated; Sponsor: University of Pennsylvania; Completed ➔ Terminated; Lack of efficacy and funding to continue investigation

Clinical • Trial termination